According to the company, taking the medication every other day for a week decreased migraine days by 30%, and nearly half of the participants reported a 50% reduction in moderate-to-severe
All three of the standard-of-care (SOC) medications analyzed by the researchers saw at least an 8 percent decrease in administration of the medication after price hikes. Two of the SOC
Preclinical trials of a new radiopharmaceutical for the treatment of ovarian cancer have shown promising results, with tumor growth and mass significantly reduced after use. The new radiopharmaceutical, which is
Monoamine oxidase inhibitors are a type of medicine used to treat depression. They operate by increasing levels of serotonin, the brain’s “happy hormone.” According to a recent UCLA study, such
Alzheimer's disease, Medical News, Neurocognitive disorders, Neuroscience, Pharmaceuticals, World health
The Food and Drug Administration is about to make one of its most divisive rulings in years, deciding on the destiny of an Alzheimer’s drug that might be the first
On Friday, regulators announced that a new version of a popular diabetes medicine would be sold in the United States as a weight-loss treatment. Wegovy, a higher-dose variant of Novo